NPCUF — Allon Therapeutics Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Allon Therapeutics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2008 December 31st | 2009 December 31st | R2010 December 31st | C2011 December 31st | 2012 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 12.6 | 7.28 | 16.4 | 12.6 | 14.9 |
| Operating Profit | -12.6 | -7.28 | -16.4 | -12.6 | -14.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -11.3 | -7.34 | -16.1 | -12.8 | -14.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -11.3 | -7.34 | -16.1 | -12.8 | -14.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -11.3 | -7.34 | -16.1 | -12.8 | -14.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -11.3 | -7.34 | -16.1 | -12.8 | -14.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.167 | -0.094 | -0.206 | -0.155 | -0.087 |
| Dividends per Share |